Guangzhou Concord Cancer Center Showcases Proton Therapy at Bangladesh Medical Expo, Attracting Strong Interest from South Asia
Guangzhou Concord Cancer Center participated in the 17th Dhaka International Medical Equipment Exhibition, presenting its proton therapy technology and precision oncology capabilities to healthcare providers and patients from South Asia.
As the first operational proton therapy center in South China, Guangzhou Concord Cancer Center introduced a new treatment option for cancer patients seeking advanced radiotherapy solutions.
The Dhaka Medical Equipment Exhibition is one of Bangladesh's largest and most influential healthcare industry events, attracting hospitals, medical distributors, and healthcare service providers from multiple countries.
As a high-level oncology hospital with international service capabilities, Guangzhou Concord Cancer Center showcased its expertise in precision oncology and established new pathways for cross-border medical cooperation and patient access in South Asia.
A dedicated consultation booth was set up on-site to provide one-on-one consultations for hospitals, medical travel facilitators, and prospective patients — introducing cancer treatment pathways, indications for proton therapy, and full-process international patient services.
On-site consultation booth at the Dhaka exhibition.
Healthcare professionals engage with GCCC representatives.
"In cross-border healthcare services, we have developed a mature end-to-end international patient service system, including medical record pre-evaluation, cross-border referral coordination, visa assistance, multilingual interpretation, dedicated case management, international insurance direct billing, and post-treatment follow-up care." — Mr. You Jin, Head of International Medical Services and Insurance Cooperation
During the exhibition, many patients inquired about the differences between proton therapy and conventional radiotherapy. Ms. Zhou Minping, Deputy Director of the Nursing Department, provided clinical explanations, noting that proton therapy uses the Bragg Peak effect to precisely deliver radiation to the tumor while significantly reducing exposure to healthy organs such as the heart and lungs.
"In cross-border care, patients often face unfamiliar environments, language barriers, and cultural differences, which require highly specialized nursing support. We have established a full-cycle care pathway covering admission, inpatient care, discharge, and remote follow-up. Multilingual educational materials and videos are used to help patients understand every stage of treatment." — Ms. Zhou Minping, Deputy Director of the Nursing Department
Ms. Zhou Minping explains proton therapy clinical pathways to attending visitors.
As the first clinically operational proton therapy institution in South China, Guangzhou Concord Cancer Center aligns its standards with leading global cancer centers such as MD Anderson Cancer Center and Mayo Clinic, establishing a multidisciplinary precision oncology system.
The hospital is committed to expanding China's advanced oncology capabilities globally, meeting international patient demand for high-quality cancer care while promoting cross-border medical collaboration.
International patients have come from over 20 countries and regions including Indonesia, Bangladesh, the Philippines, and the Middle East.
International patient receiving proton therapy treatment at Guangzhou Concord Cancer Center.
Bangladesh, as the first South Asian country to participate in the Belt and Road Initiative, has seen steadily growing demand for cross-border healthcare services under supportive national policies.
According to available data:
In 2025, major international hospitals in China received 12.8 million foreign patient visits — a 73.6% increase compared to three years earlier.
In Guangdong Province, inpatient demand from foreign patients increased by 76.05% year-on-year.
These trends highlight the rapid growth of cross-border demand for advanced oncology treatments across Asia.
Healthcare professionals from Bangladesh engage in discussion at the GCCC booth.
The GCCC delegation at the 17th Dhaka International Medical Equipment Exhibition.
Leveraging its participation in the Bangladesh exhibition, Guangzhou Concord Cancer Center will strengthen partnerships with overseas hospitals and referral networks, further improving its cross-border healthcare service system.
The hospital will continue promoting advanced oncology technologies such as proton therapy, expanding global access to high-quality cancer care and contributing to the development of international healthcare.